KHN Morning Briefing

Summaries of health policy coverage from major news organizations

full issue

State Highlights: Ohio Legislature Mulls Bill Banning Down-Syndrome Related Abortions; Mental Health Experts Struggle With Chicago’s Gun Violence

Media outlets report on news from Ohio, New Hampshire, California, Illinois and Minnesota.

PBS NewsHour: Chicago’s Gun Violence Crisis Is Also A Mental Health Crisis
In 2016, there were more than 4,000 shootings and 762 homicides in the city, according to the Chicago Police Department — a nearly 60 percent increase from 2015. ... Between 2009 and 2012, the state cut $113.7 million in funding for mental health services, according to National Alliance on Mental Illness’ (NAMI) Chicago branch. (Connelly Holmes, 8/22)

Los Angeles Times: Jury Begins Deliberating Sanity Of Man Convicted Of Killing Newport Beach Urologist
An Orange County Superior Court jury began deliberating Tuesday whether a 79-year-old Lake Elsinore man was legally insane the day he fatally shot his former Newport Beach doctor in 2013. On Monday, the 12-member jury swiftly convicted Stanwood Elkus, a retired barber, of first-degree murder in the slaying of Dr. Ronald Gilbert, who had been Elkus’ urologist years earlier. Prosecutors said Elkus used a fake name to get an appointment in Gilbert’s Newport office, where he shot the 52-year-old physician 10 times after he walked into the exam room. (Fry, 8/22)

Denver Post: Children's Hospital Colorado Preparing 25 New Cancer Trials
Doctors at Children’s Hospital Colorado hope to launch as many as 25 new clinical trials in the next six months after a recently signed federal law opened the floodgates to test experimental cancer drugs for children .“The pediatric oncology community is really excited,” said Dr. Lia Gore, the director of Children’s Center for Cancer and Blood Disorders. While there are hundreds of cancer drugs in development to treat adults, research on pediatric cancer drugs has historically lagged. Gore said essentially only four new drugs have been approved to treat childhood cancer since 1979. (Ingold, 8/22)

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.